InvestSMART

Dorsavi Ltd (ASX: DVL) - Announcements

- Current share price for DVL : $0.022

ASX company news and announcements for Dorsavi Ltd (DVL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dorsavi Ltd (DVL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dorsavi Ltd (DVL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dorsavi Ltd (DVL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 Application for quotation of securities - DVL 27 Jun 2025 4:52PM $0.016 $0.022 risen by 37.50%
$27 Application for quotation of securities - DVL 27 Jun 2025 4:51PM $0.016 $0.022 risen by 37.50%
$27 Proposed issue of securities - DVL 12 Jun 2025 9:12AM $0.016 $0.022 risen by 37.50%
$27 Proposed issue of securities - DVL 12 Jun 2025 9:12AM $0.016 $0.022 risen by 37.50%
$27 Proposed issue of securities - DVL 12 Jun 2025 9:12AM $0.016 $0.022 risen by 37.50%
$27 Proposed issue of securities - DVL 12 Jun 2025 9:12AM $0.016 $0.022 risen by 37.50%
$27 dorsaVi Secures Exclusive Worldwide RRAM Licence 12 Jun 2025 9:12AM $0.016 $0.022 risen by 37.50%
$27 Trading Halt 10 Jun 2025 9:17AM $0.016 $0.022 risen by 37.50%
$27 dorsaVi Signs 3-year Deal with Mining Health Leader 30 May 2025 9:52AM $0.013 $0.022 risen by 69.23%
$27 dorsaVi expands AI platform into workplace safety 9 May 2025 9:03AM $0.009 $0.022 risen by 144.44%
$27 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 10:00AM $0.007 $0.022 risen by 214.29%
$27 Notification of cessation of securities - DVL 11 Apr 2025 3:52PM $0.007 $0.022 risen by 214.29%
$27 DVL launches 3D motion analysis test to reduce ACL injuries 18 Mar 2025 9:14AM $0.007 $0.022 risen by 214.29%
$27 Appendix 4D and Half Year Financial Report 26 Feb 2025 4:49PM $0.009 $0.022 risen by 144.44%
$27 dorsaVi Announces new deal with prominent US Surgeon 3 Feb 2025 9:37AM $0.010 $0.022 risen by 120%
$27 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 9:45AM $0.010 $0.022 risen by 120%
$27 Notification of cessation of securities - DVL 10 Jan 2025 4:33PM $0.011 $0.022 risen by 100%
$27 Secret Network Partnership to enhance Blockchain capability 17 Dec 2024 9:05AM $0.012 $0.022 risen by 83.33%
$27 dorsaVi Commercial Release of AI-Powered Video Platform 13 Dec 2024 8:57AM $0.014 $0.022 risen by 57.14%
$27 Notification of cessation of securities - DVL 11 Dec 2024 5:55PM $0.014 $0.022 risen by 57.14%
$27 Initial Director's Interest Notice 6 Dec 2024 6:32PM $0.013 $0.022 risen by 69.23%
$27 Experienced Blockchain and Technology Director appointment 4 Dec 2024 8:55AM $0.013 $0.022 risen by 69.23%
$27 Results of Annual General Meeting 27 Nov 2024 2:46PM $0.014 $0.022 risen by 57.14%
$27 DVL Progresses Blockchain Integration Planning POC Study 25 Nov 2024 8:56AM $0.013 $0.022 risen by 69.23%
$27 Change of Director's Interest Notices X3 22 Nov 2024 4:22PM $0.013 $0.022 risen by 69.23%

126 - 150 of 762 results

Page 6 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.